These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25483702)

  • 41. Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.
    Sibley L; Reljic R; Radford DS; Huang JM; Hong HA; Cranenburgh RM; Cutting SM
    FEMS Microbiol Lett; 2014 Sep; 358(2):170-9. PubMed ID: 24990572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines.
    Tang X; Yang Y; Xia X; Zhang C; Yang X; Song Y; Dai X; Wang M; Zhou D
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
    Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L
    Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
    Kammoun H; Roux X; Raze D; Debrie AS; De Filette M; Ysenbaert T; Mielcarek N; Saelens X; Fiers W; Locht C
    PLoS One; 2013; 8(3):e59198. PubMed ID: 23555631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens.
    Zhang X; Liu M; Liu C; Du J; Shi W; Sun E; Li H; Li J; Zhang Y
    Intervirology; 2011; 54(5):290-9. PubMed ID: 21228535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.
    Wibowo N; Hughes FK; Fairmaid EJ; Lua LH; Brown LE; Middelberg AP
    Vaccine; 2014 Jun; 32(29):3651-5. PubMed ID: 24795225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
    Wu F; Yuan XY; Huang WS; Chen YH
    Vaccine; 2009 Oct; 27(43):6095-101. PubMed ID: 19056447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
    De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
    Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
    Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
    Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection.
    Tao W; Gill HS
    Vaccine; 2015 May; 33(20):2307-15. PubMed ID: 25842219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.
    Denis J; Acosta-Ramirez E; Zhao Y; Hamelin ME; Koukavica I; Baz M; Abed Y; Savard C; Pare C; Lopez Macias C; Boivin G; Leclerc D
    Vaccine; 2008 Jun; 26(27-28):3395-403. PubMed ID: 18511159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
    Liu X; Guo J; Han S; Yao L; Chen A; Yang Q; Bo H; Xu P; Yin J; Zhang Z
    Vaccine; 2012 Oct; 30(46):6527-33. PubMed ID: 22959982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza A viruses: why focusing on M2e-based universal vaccines.
    Ebrahimi SM; Tebianian M
    Virus Genes; 2011 Feb; 42(1):1-8. PubMed ID: 21082230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High copy numbers and N terminal insertion position of influenza A M2E fused with hepatitis B core antigen enhanced immunogenicity.
    Sun X; Wang Y; Dong C; Hu J; Yang L
    Biosci Trends; 2015 Aug; 9(4):221-7. PubMed ID: 26355223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunological characteristics and probiotic function of recombinant Bacillus subtilis spore expressing Clonorchis sinensis cysteine protease.
    Tang Z; Shang M; Chen T; Ren P; Sun H; Qu H; Lin Z; Zhou L; Yu J; Jiang H; Zhou X; Li X; Huang Y; Xu J; Yu X
    Parasit Vectors; 2016 Dec; 9(1):648. PubMed ID: 27993173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Construction, expression and immunogenicity analysis of a fusion protein containing M2e of influenza A virus fused to a modified Pseudomonas aeruginosa exotoxin A].
    Xu Y; Yao LH; Chen AJ; Guo JQ; Liu XY; Bo H; Liu LQ; Shu YL; Zhang ZQ
    Bing Du Xue Bao; 2010 May; 26(3):189-94. PubMed ID: 20572339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. M2-based influenza vaccines: recent advances and clinical potential.
    Kolpe A; Schepens B; Fiers W; Saelens X
    Expert Rev Vaccines; 2017 Feb; 16(2):123-136. PubMed ID: 27653543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
    Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonosoff GP; Ravin NV
    BMC Biotechnol; 2015 May; 15():42. PubMed ID: 26022390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.